{"DataElement":{"publicId":"3461833","version":"1","preferredName":"Anaplastic Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for anaplastic cancer.","longName":"3461763v1.0:3461826v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3461763","version":"1","preferredName":"Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Stage Grouping","preferredDefinition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"3461761v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3461761","version":"1","preferredName":"Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","preferredDefinition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive.","longName":"C3878","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Anaplastic Carcinoma","conceptCode":"C3878","definition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-00FD-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C03DD87C-010B-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8-30-19 TMT transferred from NCIP to NCI Standards. Created for CRF standard harmonization. mc 5/17/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3461826","version":"1","preferredName":"Thyroid Gland Undifferentiated (Anaplastic) Carcinoma American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3461826v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03E0DED-63DB-9912-E040-BB89AD437BF5","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","ValueMeaning":{"publicId":"3461827","version":"1","preferredName":"Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","longName":"3461827","preferredDefinition":"Stage IVA includes: T4a, Any N, M0.  T4a: Intrathyroidal anaplastic carcinoma. M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7","conceptCode":"C87552","definition":"Stage IVA includes: T4a, Any N, M0.  T4a: Intrathyroidal anaplastic carcinoma. M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03E0DED-63E7-9912-E040-BB89AD437BF5","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03E0DED-6400-9912-E040-BB89AD437BF5","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","ValueMeaning":{"publicId":"3461828","version":"1","preferredName":"Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","longName":"3461828","preferredDefinition":"Stage IVB includes: T4b, Any N, M0.  T4b: Anaplastic carcinoma with gross extrathyroid extension.  M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7","conceptCode":"C87553","definition":"Stage IVB includes: T4b, Any N, M0.  T4b: Anaplastic carcinoma with gross extrathyroid extension.  M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03E0DED-640C-9912-E040-BB89AD437BF5","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03E0DED-6425-9912-E040-BB89AD437BF5","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"IVC","valueDescription":"Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","ValueMeaning":{"publicId":"3461829","version":"1","preferredName":"Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","longName":"3461829","preferredDefinition":"Stage IVC includes: Any T, Any N, M1.  M1: Distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7","conceptCode":"C87554","definition":"Stage IVC includes: Any T, Any N, M1.  M1: Distant metastasis.  (AJCC 7th ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03E0DED-6431-9912-E040-BB89AD437BF5","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03E0DED-644A-9912-E040-BB89AD437BF5","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3461825","version":"1","preferredName":"Thyroid Gland Undifferentiated (Anaplastic) Carcinoma American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C3878:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Anaplastic Carcinoma","conceptCode":"C3878","definition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03E0DED-63B2-9912-E040-BB89AD437BF5","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03E0DED-63C3-9912-E040-BB89AD437BF5","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"COOPERM","dateModified":"2012-05-17","changeDescription":"Created for CRF standard harmonization. mc 5/17/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434443","version":"1","longName":"Thyroid","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000283","version":"1","longName":"Thyroid","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"AJCC 7th Edition Manual Note","type":"NOTE","description":"All anaplastic carcinomas are considered Stage IV","url":null,"context":"NCIP"},{"name":"Anaplastic Disease Stage","type":"Preferred Question Text","description":"Anaplastic Disease Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"C03E0DED-6502-9912-E040-BB89AD437BF5","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization and released per community approval. mc 5/17/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}